Clinical Trial Update: Human Models of Selective Insulin Resistance: Alpelisib, Part I [Phase 1]

View source ↗

Summary

Clinical trial update for a Phase 1 study evaluating alpelisib in models of selective insulin resistance, investigating its effects in insulin resistance, predi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insulin Resistance
• Nonalcoholic Fatty Liver Disease
• Obesity
• Overweight
• Prediabetes

Drugs mentioned

• Alpelisib (alpelisib)

Snippet

Sponsor: Columbia University | Conditions: Insulin Resistance, Prediabetic State | Phase 1 | Status: RECRUITING